VARIVAX
Powder and solvent for suspension for injection in pre-filled syringe, najmanje 1350PFU/0.5ml
RxActive license
Active substance (INN)
varicella vaccine, live attenuated
Pharmaceutical form
Pharmaceutical formPowder and solvent for suspension for injection in pre-filled syringe
Strengthnajmanje 1350PFU/0.5ml
PackagingUkupno 1 bočica sa praškom i 1 napunjeni injekcioni špric sa rastvaračem za suspenziju (1x0.5ml) u kartonskoj kutiji
ManufacturerMerck Sharp & Dohme B.V., Netherlands
Therapeutic groupAnti-infectives for systemic use (J07BK01)
Marketing authorization holderDRUŠTVO ZA TRGOVINU NA VELIKO FARMACEUTSKIM PROIZVODIMA "GLOSARIJ" D.O.O.-PODGORICA
Authorization dateNovember 6, 2024
Source: CInMED register